These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38857662)

  • 21. Surface analysis of sequential semi-solvent vapor impact (SAVI) for studying microstructural arrangements of poly(lactide-co-glycolide) microparticles.
    Garner J; Skidmore S; Hadar J; Park H; Park K; Qin B; Wang Y
    J Control Release; 2022 Oct; 350():600-612. PubMed ID: 36057396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation of fast dissolving glucose porogens and poly(lactic-co-glycolic acid) microparticles within calcium phosphate cements for bone tissue regeneration.
    Smith BT; Lu A; Watson E; Santoro M; Melchiorri AJ; Grosfeld EC; van den Beucken JJJP; Jansen JA; Scott DW; Fisher JP; Mikos AG
    Acta Biomater; 2018 Sep; 78():341-350. PubMed ID: 30075321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods.
    Zhang XQ; Intra J; Salem AK
    J Microencapsul; 2008 Feb; 25(1):1-12. PubMed ID: 18188727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading.
    Ahmed AR; Bodmeier R
    Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.
    Sharifi F; Otte A; Yoon G; Park K
    J Control Release; 2020 Sep; 325():347-358. PubMed ID: 32645336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of microparticles for controlled release of resveratrol to adipose tissue and the impact of drug loading on particle morphology and drug release.
    Isely C; Hendley MA; Murphy KP; Kader S; Annamalai P; Jabbari E; Gower RM
    Int J Pharm; 2019 Sep; 568():118469. PubMed ID: 31265884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabrication of chitosan/polyvinylpyrrolidone hydrogel scaffolds containing PLGA microparticles loaded with dexamethasone for biomedical applications.
    Saeedi Garakani S; Davachi SM; Bagher Z; Heraji Esfahani A; Jenabi N; Atoufi Z; Khanmohammadi M; Abbaspourrad A; Rashedi H; Jalessi M
    Int J Biol Macromol; 2020 Dec; 164():356-370. PubMed ID: 32682976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.
    Cocks E; Alpar O; Somavarapu S; Greenleaf D
    Drug Dev Ind Pharm; 2015 Mar; 41(3):522-8. PubMed ID: 24650006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketorolac-Loaded PLGA-/PLA-Based Microparticles Stabilized by Hyaluronic Acid: Effects of Formulation Composition and Emulsification Technique on Particle Characteristics and Drug Release Behaviors.
    Wongrakpanich A; Khunkitchai N; Achayawat Y; Suksiriworapong J
    Polymers (Basel); 2023 Jan; 15(2):. PubMed ID: 36679147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled Release of Lysozyme from Double-Walled Poly(Lactide-Co-Glycolide) (PLGA) Microspheres.
    Ansary RH; Rahman MM; Mohamad N; Arrif TM; Latif AZA; Katas H; Nik WSBW; Awang MB
    Polymers (Basel); 2017 Oct; 9(10):. PubMed ID: 30965787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
    Uchida T; Yagi A; Oda Y; Goto S
    J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant encapsulated porous poly(lactide-co-glycolide) microparticles for developing long acting inhalation system.
    Yoo NY; Youn YS; Oh NM; Oh KT; Lee DK; Cha KH; Oh YT; Lee ES
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):419-24. PubMed ID: 21820282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Doolaanea AA
    Drug Deliv Transl Res; 2016 Jun; 6(3):308-18. PubMed ID: 26817478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Monolithic dispersions studied at lower temperatures.
    Tamani F; Bassand C; Hamoudi MC; Siepmann F; Siepmann J
    Int J Pharm; 2021 Mar; 596():120220. PubMed ID: 33486018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method.
    Coombes AG; Yeh MK; Lavelle EC; Davis SS
    J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
    Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
    J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.